ORAGENICS INCOGENEarnings & Financial Report
NYSE
OGEN Q4 2023 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-12.8M
Net Profit
$-12.7M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-5.41
ORAGENICS INC Q4 2023 Financial Summary
ORAGENICS INC reported revenue of $0 for Q4 2023, with a net profit of $-12.7M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-12.7M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 2023 |
ORAGENICS INC Annual Revenue by Year
ORAGENICS INC annual revenue history includes year-by-year totals (for example, 2023 revenue was $37.7K).
| Year | Annual Revenue |
|---|---|
| 2023 | $37.7K |
| 2022 | $131.5K |
Income Statement
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15083 | $30391 | $86047 | $0 | $17024 | $13163 | $7466 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | 12.9% | -56.7% | -91.3% | N/A |
Balance Sheet
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $22.2M | $18.5M | $15.0M | $14.8M | $12.1M | $8.5M | $7.9M | $5.0M |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $1.8M |
| Equity | $20.5M | $16.8M | $13.3M | $13.0M | $10.2M | $7.3M | $6.5M | $3.2M |
Cash Flow
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-5.6M | $-3.4M | $-3.8M | $-2.4M | $-2.1M | $-2.6M | $-1.5M | $-1.1M |